Viatris, Inc. (VTRS)
16.05
+0.10
(+0.63%)
USD |
NASDAQ |
Feb 11, 09:32
Viatris EPS Diluted (Quarterly) : -0.1101 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Boston Scientific Corp. | 0.4493 |
| Amgen, Inc. | 2.45 |
| QuidelOrtho Corp. | -10.78 |
| Indivior Pharmaceuticals, Inc. | 0.3256 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.20M |
| Revenue (Quarterly) | 3.762B |
| Total Expenses (Quarterly) | 3.890B |
| Enterprise Value | 31.99B |
| Gross Profit Margin (Quarterly) | 36.87% |
| Profit Margin (Quarterly) | -3.41% |
| Earnings Yield | -19.30% |
| Operating Earnings Yield | 5.33% |
| Normalized Earnings Yield | -6.995 |